chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chest discomfort, Fatigue, Night sweats, Pain in extremity
Clinical narrative: strick pain though out the day above each side of hips, maybe kidney or ovaries; lower back pain goingup the spine; lower back pain; severe headaches; strick pain though out the day above each side of hips, maybe kidney or ovaries; pain in arm; chest pain; night sweat; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 08May2021 at 00:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 09May2021 at 00:00, on the day 1, the patient experienced pain in arm, chest pain and night sweat. On 10May2021, on the day 2, the patient experienced strick pain though out the day above each side of hips, maybe kidney or ovaries. On 12May2021, on the day 4, the patient experienced lower back pain and severe headaches. On 16May2021, on the day 8, the patient experienced continue lower back pain going up the spine. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events  pain in arm, chest pain and night sweat, strick pain though out the day above each side of hips, maybe kidney or ovaries, lower back pain and severe headaches and continue lower back pain going up the spine were not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Adnexa uteri pain, Back pain, Chest pain, Headache, Night sweats
Clinical narrative: strick pain though out the day above each side of hips, maybe kidney or ovaries; lower back pain goingup the spine; lower back pain; severe headaches; strick pain though out the day above each side of hips, maybe kidney or ovaries; pain in arm; chest pain; night sweat; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 08May2021 at 00:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 09May2021 at 00:00, on the day 1, the patient experienced pain in arm, chest pain and night sweat. On 10May2021, on the day 2, the patient experienced strick pain though out the day above each side of hips, maybe kidney or ovaries. On 12May2021, on the day 4, the patient experienced lower back pain and severe headaches. On 16May2021, on the day 8, the patient experienced continue lower back pain going up the spine. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events  pain in arm, chest pain and night sweat, strick pain though out the day above each side of hips, maybe kidney or ovaries, lower back pain and severe headaches and continue lower back pain going up the spine were not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Renal pain, Spinal pain
Clinical narrative: strick pain though out the day above each side of hips, maybe kidney or ovaries; lower back pain goingup the spine; lower back pain; severe headaches; strick pain though out the day above each side of hips, maybe kidney or ovaries; pain in arm; chest pain; night sweat; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 08May2021 at 00:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 09May2021 at 00:00, on the day 1, the patient experienced pain in arm, chest pain and night sweat. On 10May2021, on the day 2, the patient experienced strick pain though out the day above each side of hips, maybe kidney or ovaries. On 12May2021, on the day 4, the patient experienced lower back pain and severe headaches. On 16May2021, on the day 8, the patient experienced continue lower back pain going up the spine. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events  pain in arm, chest pain and night sweat, strick pain though out the day above each side of hips, maybe kidney or ovaries, lower back pain and severe headaches and continue lower back pain going up the spine were not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Had a fever of 103.8F( 39.9C); Heart rate while resting went up to 117bpm.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 02May2021 at 10:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin and sulfa. The patient did not receive any medication within two weeks of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 20:00 the patient experienced fever of 103.8 Fahrenheit (39.9 Centigrade) and heart rate while resting went up to 117 beats per minute. Therapeutic measures were taken as a result of events and included treatment with TYLENOL. On 02May2021 the patient underwent tests which include body temperature and the result was 103.8 degrees Fahrenheit and also heart rate and the result was 117 beats per minute. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event fever of 103.8 Fahrenheit (39.9 Centigrade) and heart rate while resting went up to 117 beats per minute was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Heart rate, Heart rate increased, Pyrexia
Clinical narrative: Had a fever of 103.8F( 39.9C); Heart rate while resting went up to 117bpm.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 02May2021 at 10:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin and sulfa. The patient did not receive any medication within two weeks of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 20:00 the patient experienced fever of 103.8 Fahrenheit (39.9 Centigrade) and heart rate while resting went up to 117 beats per minute. Therapeutic measures were taken as a result of events and included treatment with TYLENOL. On 02May2021 the patient underwent tests which include body temperature and the result was 103.8 degrees Fahrenheit and also heart rate and the result was 117 beats per minute. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event fever of 103.8 Fahrenheit (39.9 Centigrade) and heart rate while resting went up to 117 beats per minute was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Heavy menstrual bleeding, Menstruation irregular, Ocular hyperaemia
Clinical narrative: Patient cycle appeared on the morning of 12May2021, a week and a half/two weeks after her regular. Patient have a very regular, 28 day cycle.; Patient experienced heavy bleeding; diarrhea; blood shot eyes(which is abnormal)-they are especially red in the morning, having slept with my contacts out; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0176 and Expiration date not reported), via an unspecified route of administration, administered in arm left on 10May2021 at 14:30 (at the age of 35-year-old) as single dose for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history was reported as none. Concomitant medications included zoloft (SERTRALINE HYDROCHLORIDE) at a dose of 25 mg and strattera (ATOMOXETINE HYDROCHLORIDE) at a dose of 25 mg; both for an unspecified indication and unknown start date and end date. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient has no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0161 and Expiration date not reported), via an unspecified route of administration, administered in arm left on 19Apr2021 at 18:45 (at the age of 35-year-old) as single dose for COVID-19 immunisation at Pharmacy. On 12May2021 at 08:00, it was reported that patient cycle appeared on the morning of 12May2021, a week and a half/two weeks after her regular. Patient have a very regular 28 day cycle. Patient experienced heavy bleeding, diarrhea, and blood shot eyes (which is abnormal) - they are especially red in the morning, patient slept with her contacts out. The seriousness of all the events was reported as non-serious. No treatment was given for the events. The outcome of all events was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Heavy menstrual bleeding, Menstrual disorder, Ocular hyperaemia
Clinical narrative: Patient cycle appeared on the morning of 12May2021, a week and a half/two weeks after her regular. Patient have a very regular, 28 day cycle.; Patient experienced heavy bleeding; diarrhea; blood shot eyes(which is abnormal)-they are especially red in the morning, having slept with my contacts out; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0176 and Expiration date not reported), via an unspecified route of administration, administered in arm left on 10May2021 at 14:30 (at the age of 35-year-old) as single dose for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history was reported as none. Concomitant medications included zoloft (SERTRALINE HYDROCHLORIDE) at a dose of 25 mg and strattera (ATOMOXETINE HYDROCHLORIDE) at a dose of 25 mg; both for an unspecified indication and unknown start date and end date. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient has no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0161 and Expiration date not reported), via an unspecified route of administration, administered in arm left on 19Apr2021 at 18:45 (at the age of 35-year-old) as single dose for COVID-19 immunisation at Pharmacy. On 12May2021 at 08:00, it was reported that patient cycle appeared on the morning of 12May2021, a week and a half/two weeks after her regular. Patient have a very regular 28 day cycle. Patient experienced heavy bleeding, diarrhea, and blood shot eyes (which is abnormal) - they are especially red in the morning, patient slept with her contacts out. The seriousness of all the events was reported as non-serious. No treatment was given for the events. The outcome of all events was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; approximately 1pm fever of 101.2; approximately 12pm fatigue and body aches; approximately 12pm fatigue and body aches; Morning after approximately 9am sore arm and headache,; Morning after approximately 9am sore arm and headache,; approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; This is a spontaneous report from a contactable consumer, patient. A 15-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in a left arm on 14May2021 at 17:00(at the age of 15-year-old) as a single dose for COVID-19 immunisation. Medical history included autism, anxiety and depression. The patient did not have known allergies to food, medication or other product. The patient did not receive any medications within 2 weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not been tested for COVID-19 since the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15May2021 approximately at 09:00 the patient experienced sore arm and headache in the morning, on the same day approximately at 12:00 experienced fatigue and body aches, approximately at 13:00 experienced fever of 101.2  and approximately at 14:00 patient experienced vomiting, body aches fatigue headache and nausea continued throughout the day. The event did not result in doctor or other healthcare professional office/clinic visit. On 15May2021 the patient checked body temperature and resulted 101.2 (unspecified units). Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm and headache, fatigue, body ache, fever, vomiting and nausea were recovering, at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Fatigue, Headache, Nausea, Pain
Clinical narrative: approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; approximately 1pm fever of 101.2; approximately 12pm fatigue and body aches; approximately 12pm fatigue and body aches; Morning after approximately 9am sore arm and headache,; Morning after approximately 9am sore arm and headache,; approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; This is a spontaneous report from a contactable consumer, patient. A 15-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in a left arm on 14May2021 at 17:00(at the age of 15-year-old) as a single dose for COVID-19 immunisation. Medical history included autism, anxiety and depression. The patient did not have known allergies to food, medication or other product. The patient did not receive any medications within 2 weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not been tested for COVID-19 since the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15May2021 approximately at 09:00 the patient experienced sore arm and headache in the morning, on the same day approximately at 12:00 experienced fatigue and body aches, approximately at 13:00 experienced fever of 101.2  and approximately at 14:00 patient experienced vomiting, body aches fatigue headache and nausea continued throughout the day. The event did not result in doctor or other healthcare professional office/clinic visit. On 15May2021 the patient checked body temperature and resulted 101.2 (unspecified units). Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm and headache, fatigue, body ache, fever, vomiting and nausea were recovering, at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, Vomiting
Clinical narrative: approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; approximately 1pm fever of 101.2; approximately 12pm fatigue and body aches; approximately 12pm fatigue and body aches; Morning after approximately 9am sore arm and headache,; Morning after approximately 9am sore arm and headache,; approximately 2pm vomiting, body aches fatigue headache and nausea continued throughout the day; This is a spontaneous report from a contactable consumer, patient. A 15-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in a left arm on 14May2021 at 17:00(at the age of 15-year-old) as a single dose for COVID-19 immunisation. Medical history included autism, anxiety and depression. The patient did not have known allergies to food, medication or other product. The patient did not receive any medications within 2 weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not been tested for COVID-19 since the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 15May2021 approximately at 09:00 the patient experienced sore arm and headache in the morning, on the same day approximately at 12:00 experienced fatigue and body aches, approximately at 13:00 experienced fever of 101.2  and approximately at 14:00 patient experienced vomiting, body aches fatigue headache and nausea continued throughout the day. The event did not result in doctor or other healthcare professional office/clinic visit. On 15May2021 the patient checked body temperature and resulted 101.2 (unspecified units). Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm and headache, fatigue, body ache, fever, vomiting and nausea were recovering, at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Fatigue, Nausea, Pain
Clinical narrative: had very little soreness the first day. WhenI woke up the next day, my arm hurtvery badly.; nausea; dizziness; chills mild; feverish feeling; moderate fatigue; had a very mild sharp, needle-like pain.; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13May2021 at 14:45 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 14:45, the patient experienced a very mild sharp, needle-like pain. On 14May2021, the patient experienced arm hurt very badly. Throughout the day had moderate fatigue. Also, had nausea, dizziness, chills, and a feverish feeling all those symptoms were mild. Patient also stated he had a light, protein-filled dinner that night. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL 325 mg. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm hurt very badly, moderate fatigue, nausea, dizziness, chills, and a feverish feeling was recovered on an unspecified date in May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: had very little soreness the first day. WhenI woke up the next day, my arm hurtvery badly.; nausea; dizziness; chills mild; feverish feeling; moderate fatigue; had a very mild sharp, needle-like pain.; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13May2021 at 14:45 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 14:45, the patient experienced a very mild sharp, needle-like pain. On 14May2021, the patient experienced arm hurt very badly. Throughout the day had moderate fatigue. Also, had nausea, dizziness, chills, and a feverish feeling all those symptoms were mild. Patient also stated he had a light, protein-filled dinner that night. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL 325 mg. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm hurt very badly, moderate fatigue, nausea, dizziness, chills, and a feverish feeling was recovered on an unspecified date in May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: had very little soreness the first day. WhenI woke up the next day, my arm hurtvery badly.; nausea; dizziness; chills mild; feverish feeling; moderate fatigue; had a very mild sharp, needle-like pain.; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13May2021 at 14:45 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021 at 14:45, the patient experienced a very mild sharp, needle-like pain. On 14May2021, the patient experienced arm hurt very badly. Throughout the day had moderate fatigue. Also, had nausea, dizziness, chills, and a feverish feeling all those symptoms were mild. Patient also stated he had a light, protein-filled dinner that night. Therapeutic measures were taken as a result of the events and included treatment with TYLENOL 325 mg. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events arm hurt very badly, moderate fatigue, nausea, dizziness, chills, and a feverish feeling was recovered on an unspecified date in May2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Limb discomfort, Paraesthesia, Paraesthesia oral
Clinical narrative: Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly.; Waves of vertigo; Waves of tingling in lips, face, and extremities; Waves of tingling in lips, face, and extremities; During a spell, weak grip in hand; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 07May2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hay fever (seasonal hay fever) and penicillin allergy. Concomitant medications included ascorbic acid, pyridoxal phosphate, thiamine hydrochloride, riboflavin sodium phosphate, calcium pantothenate, adrenal cortical extract, glycyrrhiza glabra root, zinc bis glycinate chelate, adrenal gland (CORTREX), vitamin D nos (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN) all for unknown indications and since an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, 6 days after vaccination, the patient experienced waves of vertigo, waves of tingling in lips, face, and extremities. During a spell, weak grip in hand. Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly. The patient had been resting and may seek out medical care if it persists. The patient did not receive any treatment for the events. The clinical outcome of the events vertigo, waves of tingling in lips, face, and extremities, weak grip in hand, feet/calves feeling heavy were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly.; Waves of vertigo; Waves of tingling in lips, face, and extremities; Waves of tingling in lips, face, and extremities; During a spell, weak grip in hand; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 07May2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hay fever (seasonal hay fever) and penicillin allergy. Concomitant medications included ascorbic acid, pyridoxal phosphate, thiamine hydrochloride, riboflavin sodium phosphate, calcium pantothenate, adrenal cortical extract, glycyrrhiza glabra root, zinc bis glycinate chelate, adrenal gland (CORTREX), vitamin D nos (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN) all for unknown indications and since an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, 6 days after vaccination, the patient experienced waves of vertigo, waves of tingling in lips, face, and extremities. During a spell, weak grip in hand. Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly. The patient had been resting and may seek out medical care if it persists. The patient did not receive any treatment for the events. The clinical outcome of the events vertigo, waves of tingling in lips, face, and extremities, weak grip in hand, feet/calves feeling heavy were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Grip strength decreased, Paraesthesia, Paraesthesia oral, Vertigo
Clinical narrative: Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly.; Waves of vertigo; Waves of tingling in lips, face, and extremities; Waves of tingling in lips, face, and extremities; During a spell, weak grip in hand; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 07May2021 at 09:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hay fever (seasonal hay fever) and penicillin allergy. Concomitant medications included ascorbic acid, pyridoxal phosphate, thiamine hydrochloride, riboflavin sodium phosphate, calcium pantothenate, adrenal cortical extract, glycyrrhiza glabra root, zinc bis glycinate chelate, adrenal gland (CORTREX), vitamin D nos (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN) all for unknown indications and since an unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13May2021, 6 days after vaccination, the patient experienced waves of vertigo, waves of tingling in lips, face, and extremities. During a spell, weak grip in hand. Feet/calves feeling heavy. Mostly affecting left side of body. Comes and goes randomly. The patient had been resting and may seek out medical care if it persists. The patient did not receive any treatment for the events. The clinical outcome of the events vertigo, waves of tingling in lips, face, and extremities, weak grip in hand, feet/calves feeling heavy were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Dysphagia, Dyspnoea, Hypoaesthesia oral
Clinical narrative: wheezing; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 15May2021 at 11:30 (Lot Number: EW0183) (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 02Apr2021 at 11:00 (Lot Number: EW0151) for COVID-19 immunisation and experienced allergic reaction, could not swallow, hard to swallow/breathe, tongue become numb, red bump where injection was given, funny metal taste, and fatigue. The patient experienced wheezing (medically significant) on 15May2021 at 11:30. The event required visit to emergency room and physician office. The patient underwent lab tests and procedures which included allergy test: result unknown (reaction to her testing that received 3 breathing treatment, 5 shot for testing). On an unspecified date. Unspecified therapeutic measures were taken as a result of wheezing. The patient outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ageusia, Allergy test, Fatigue, Hypersensitivity, Vaccination site erythema
Clinical narrative: wheezing; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 15May2021 at 11:30 (Lot Number: EW0183) (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 02Apr2021 at 11:00 (Lot Number: EW0151) for COVID-19 immunisation and experienced allergic reaction, could not swallow, hard to swallow/breathe, tongue become numb, red bump where injection was given, funny metal taste, and fatigue. The patient experienced wheezing (medically significant) on 15May2021 at 11:30. The event required visit to emergency room and physician office. The patient underwent lab tests and procedures which included allergy test: result unknown (reaction to her testing that received 3 breathing treatment, 5 shot for testing). On an unspecified date. Unspecified therapeutic measures were taken as a result of wheezing. The patient outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: wheezing; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 15May2021 at 11:30 (Lot Number: EW0183) (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 02Apr2021 at 11:00 (Lot Number: EW0151) for COVID-19 immunisation and experienced allergic reaction, could not swallow, hard to swallow/breathe, tongue become numb, red bump where injection was given, funny metal taste, and fatigue. The patient experienced wheezing (medically significant) on 15May2021 at 11:30. The event required visit to emergency room and physician office. The patient underwent lab tests and procedures which included allergy test: result unknown (reaction to her testing that received 3 breathing treatment, 5 shot for testing). On an unspecified date. Unspecified therapeutic measures were taken as a result of wheezing. The patient outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Allergy test, Wheezing
Clinical narrative: wheezing; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 15May2021 at 11:30 (Lot Number: EW0183) (at the age of 60-year-old) as single dose for COVID-19 immunisation. Medical history was not reported. The patient's concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in arm left on 02Apr2021 at 11:00 (Lot Number: EW0151) for COVID-19 immunisation and experienced allergic reaction, could not swallow, hard to swallow/breathe, tongue become numb, red bump where injection was given, funny metal taste, and fatigue. The patient experienced wheezing (medically significant) on 15May2021 at 11:30. The event required visit to emergency room and physician office. The patient underwent lab tests and procedures which included allergy test: result unknown (reaction to her testing that received 3 breathing treatment, 5 shot for testing). On an unspecified date. Unspecified therapeutic measures were taken as a result of wheezing. The patient outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer, the patient. An 18-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0167) via an unspecified route of administration in the left arm on 03May2021 at 12:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0162) via an unspecified route of administration in the left arm on 12Apr2021 at 12:00 (at the age of 18-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09May2021 at 15:00, the patient experienced shingles. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with shingle cream, Valacyclovir and Tylenol. The clinical outcome of the event shingles was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: slow but steady start and increasingly worsening muscle aches; chills; severe tiredness; Deep sleep for 12+ hours; mild pinging headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZW0185) via an unspecified route of administration in the arm left on 14May2021 at 17:00(at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit disorder and post-traumatic stress disorder(PTSD). Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), norethisterone acetate, ethinylestradiol, ferrous fumarate (LARIN FE 1/20) and colecalciferol, menaquinone-7 (VITAMIN K2 + D3); from an unknown date for unknown indications. The patient had no known allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 23Apr2021 at 12:15 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 the patient experienced mild pinging headache. On 15May2021 around 11:30 the patient experienced slow but steady start and increasingly worsening muscle aches, chills, tiredness and Deep sleep for 12+ hours. Therapeutic measures were taken for headache and included treatment herself with water and ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, worsening muscle aches, chills, tiredness and Deep sleep for 12+ hours was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pingueculitis, Pyrexia, Vomiting
Clinical narrative: slow but steady start and increasingly worsening muscle aches; chills; severe tiredness; Deep sleep for 12+ hours; mild pinging headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZW0185) via an unspecified route of administration in the arm left on 14May2021 at 17:00(at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit disorder and post-traumatic stress disorder(PTSD). Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), norethisterone acetate, ethinylestradiol, ferrous fumarate (LARIN FE 1/20) and colecalciferol, menaquinone-7 (VITAMIN K2 + D3); from an unknown date for unknown indications. The patient had no known allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 23Apr2021 at 12:15 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 the patient experienced mild pinging headache. On 15May2021 around 11:30 the patient experienced slow but steady start and increasingly worsening muscle aches, chills, tiredness and Deep sleep for 12+ hours. Therapeutic measures were taken for headache and included treatment herself with water and ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, worsening muscle aches, chills, tiredness and Deep sleep for 12+ hours was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Somnolence
Clinical narrative: slow but steady start and increasingly worsening muscle aches; chills; severe tiredness; Deep sleep for 12+ hours; mild pinging headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ZW0185) via an unspecified route of administration in the arm left on 14May2021 at 17:00(at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit disorder and post-traumatic stress disorder(PTSD). Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), norethisterone acetate, ethinylestradiol, ferrous fumarate (LARIN FE 1/20) and colecalciferol, menaquinone-7 (VITAMIN K2 + D3); from an unknown date for unknown indications. The patient had no known allergies to medications, food or other products. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 23Apr2021 at 12:15 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 the patient experienced mild pinging headache. On 15May2021 around 11:30 the patient experienced slow but steady start and increasingly worsening muscle aches, chills, tiredness and Deep sleep for 12+ hours. Therapeutic measures were taken for headache and included treatment herself with water and ibuprofen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, worsening muscle aches, chills, tiredness and Deep sleep for 12+ hours was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus shrill ringing in left ear nonstop; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0175) via an unspecified route of administration in the left arm on 10May2021 at 14:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Concomitant medications included multivitamin, D3 and "2000 IUs". Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10May2021 at 21:00, the patient experienced tinnitus shrill ringing in left ear nonstop. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event tinnitus shrill ringing in left ear nonstop was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.